Gremlin-1 transcripts are found in various different tumor types and can functionally interfere with the TGF-β (transforming growth factor-beta) signaling pathway by the inhibition of the bone morphogenetic proteins BMP2 and BMP4. This evidence concerns the gene GREM1 and neoplasm.